MedTrace Logo

Piracetam for Treatment of Cocaine Addiction - 3

NCT00000198 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2015-10-06

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effects of IV cocaine administration in cocaine dependent subjects maintained on piracetam while they are residing in an inpatient addictions treatment research unit and to subsequently follow these patients in an eight week open label assessment of piracetam in an outpatient treatment program.

Conditions

  • Cocaine-Related Disorders

Interventions

DRUG

Piracetam

Sponsors & Collaborators

Principal Investigators

  • Kyle Kampman, M.D. · University of Pennsylvania

Study Design

Purpose
TREATMENT

Eligibility

Min Age
21 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-10-31
Primary Completion
1997-10-31
Completion
1997-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000198 on ClinicalTrials.gov